Publications and Reports
Adverse Event Reporting
Blood and Blood Products
Immunoglobulins
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2022/23
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2021/22
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2020/21
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2019/20
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2018/19
- IVIG and SCIG Utlization in the Atlantic Procinces Fiscal Year 2017/18
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2016/17
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2015/16
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2014/15
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2013/14
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2012/13
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2011/12
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2010/11
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2009/10
- IVIG and SCIG Utilization in the Atlantic Provinces Fiscal Year 2008/09
Components
- Nova Scotia Annual Component Utilization Report 2022-23
- Nova Scotia Red Blood Cell Report 2021/22
- Nova Scotia Red Blood Cell Report 2020/21
- Nova Scotia Red Blood Cell Report 2019/20
- Nova Scotia Red Blood Cell Report 2018/19
- Nova Scotia Red Blood Cell Report 2017/18
- Nova Scotia Red Blood Cell Report 2016/17
- Nova Scotia Red Blood Cell Report 2015/16
- Nova Scotia Red Blood Cell Report 2014/15
- Nova Scotia Red Blood Cell Report 2013/14
- Nova Scotia Red Blood Cell Report Q3-4 2011/12 and FY 2012/13
- Nova Scotia Red Blood Cell Report Q3 2008/09 to Q2 2011/12
- NS RBC Discards Report Q1 2006 - Q2 2008